z-logo
open-access-imgOpen Access
Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
Author(s) -
Smita Bhatia,
Wendy Landier,
Muyun Shangguan,
Lindsey Hageman,
Alexandra Schaible,
Andrea R. Carter,
Cara Hanby,
Wendy M. Leisenring,
Yutaka Yasui,
Nancy M. Kornegay,
Leo Mascarenhas,
A. Kim Ritchey,
Jacqueline Casillas,
David S. Dickens,
Jane L. Meza,
William L. Carroll,
Mary V. Relling,
F. Lennie Wong
Publication year - 2012
Publication title -
journal of clinical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 10.482
H-Index - 548
eISSN - 1527-7755
pISSN - 0732-183X
DOI - 10.1200/jco.2011.38.9924
Subject(s) - medicine , mercaptopurine , hazard ratio , lymphoblastic leukemia , confidence interval , cumulative incidence , incidence (geometry) , gastroenterology , pediatrics , leukemia , cohort , physics , optics
Systemic exposure to mercaptopurine (MP) is critical for durable remissions in children with acute lymphoblastic leukemia (ALL). Nonadherence to oral MP could increase relapse risk and also contribute to inferior outcome in Hispanics. This study identified determinants of adherence and described impact of adherence on relapse, both overall and by ethnicity.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom